Dianthus Therapeutics Inc. (DNTH)
Healthcare
Biotechnology
—
106.90 $
-5.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Dianthus Therapeutics Inc. (DNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -129 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.5 | -22 | -42 | -57 | -64 | -60 | -29 | -37 | -78 | -129 | |
| 0.0 | 0.4 | 0.9 | 1.8 | 2.0 | 2.0 | 0.1 | 0.4 | 0.4 | 0.4 | |
| 0.7 | 2.3 | 11 | 10 | 9.9 | 0.1 | 1.5 | 2.9 | 13 | 23 | |
| – | – | – | – | – | 0.1 | 0.9 | – | – | – | |
| 1.6 | 1.3 | 4.0 | 8.8 | -1.2 | -1.5 | -1.7 | 4.9 | -0.4 | 17 | |
| 0.1 | 2.2 | 7.7 | 3.1 | 0.4 | 1.3 | 0.1 | 0.1 | 0.1 | 0.2 | |
| -0.1 | -2.2 | -92 | 1.5 | -11 | 43 | -60 | 20 | -287 | -123 | |
| -0.1 | -0.2 | -0.1 | – | – | – | – | – | – | 0.3 | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | – | |
| 11 | 71 | 142 | 62 | 68 | 90 | 97 | 134 | 256 | 280 | |
| 4.0 | 47 | 6.8 | 6.7 | -6.9 | 73 | 7.8 | 117 | -109 | 28 | |
| -6.7 | -24 | -50 | -60 | -64 | -61 | -29 | -37 | -78 | -129 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.